Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Nayiager

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|May 2, 1987
Miliary mottling on lung fields plus hyperthyroidism--miliary tuberculosis or choriocarcinoma? A case reportS Nayiager, I Jialal, R W Green-Thompson
Critical Care Medicine|April 1, 1989
Autonomic nervous system dysfunction in severe tetanus: current perspectivesD K Wright, U G Lalloo, S Nayiager, et al.
Clinical Rheumatology|February 28, 2003
Lack of association of Human T-cell lymphotrophic virus type 1(HTLV-1) infection and rheumatoid arthritis in an endemic areaD Sebastian, S Nayiager, D Y York, et al.
Alimentary Pharmacology & Therapeutics|May 22, 2004
Reduced incidence of gastroduodenal ulcers associated with lumiracoxib compared with ibuprofen in patients with rheumatoid arthritisA J Kivitz, S Nayiager, T Schimansky, et al.
Annals of the Rheumatic Diseases|December 7, 2007
Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexateM Schiff, M Keiserman, C Codding, et al.
Annals of the Rheumatic Diseases|January 7, 2009
Clinical efficacy and safety of abatacept in methotrexate-naive patients with early rheumatoid arthritis and poor prognostic factorsR Westhovens, M Robles, A C Ximenes, et al.
Annals of the Rheumatic Diseases|August 9, 2011
Sustained disease remission and inhibition of radiographic progression in methotrexate-naive patients with rheumatoid arthritis and poor prognostic factors treated with abatacept: 2-year outcomesJ Bathon, M Robles, A C Ximenes, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|May 2, 1987
Miliary mottling on lung fields plus hyperthyroidism--miliary tuberculosis or choriocarcinoma? A case reportS Nayiager, I Jialal, R W Green-Thompson
Critical Care Medicine|April 1, 1989
Autonomic nervous system dysfunction in severe tetanus: current perspectivesD K Wright, U G Lalloo, S Nayiager, et al.
Clinical Rheumatology|February 28, 2003
Lack of association of Human T-cell lymphotrophic virus type 1(HTLV-1) infection and rheumatoid arthritis in an endemic areaD Sebastian, S Nayiager, D Y York, et al.
Alimentary Pharmacology & Therapeutics|May 22, 2004
Reduced incidence of gastroduodenal ulcers associated with lumiracoxib compared with ibuprofen in patients with rheumatoid arthritisA J Kivitz, S Nayiager, T Schimansky, et al.
Annals of the Rheumatic Diseases|December 7, 2007
Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexateM Schiff, M Keiserman, C Codding, et al.
Annals of the Rheumatic Diseases|January 7, 2009
Clinical efficacy and safety of abatacept in methotrexate-naive patients with early rheumatoid arthritis and poor prognostic factorsR Westhovens, M Robles, A C Ximenes, et al.
Annals of the Rheumatic Diseases|August 9, 2011
Sustained disease remission and inhibition of radiographic progression in methotrexate-naive patients with rheumatoid arthritis and poor prognostic factors treated with abatacept: 2-year outcomesJ Bathon, M Robles, A C Ximenes, et al.
Pageof 1